#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15166	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1995	754.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1433	1433	C	909	C	829	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	0	.	n	.	0	A20C	SNP	20	20	A	308	308	C	455	C,A	423,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	0	.	n	.	0	T695C	SNP	695	695	T	983	983	C	868	C,T	801,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	0	.	n	.	0	A1638G	SNP	1638	1638	A	1926	1926	G	875	G,A	795,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2259	2259	C	874	C,T	783,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2333	2333	A	941	A,G	879,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26776	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3419	780.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2885	2885	C	860	C,A	792,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2060	folP	855	855	100.0	folP.l15.c17.ctg.1	1528	134.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1060	1062	AGC	175;173;176	A;G;C	162;160;164	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5474	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3360	162.6	1	SNP	p	S91F	1	.	.	271	273	TTC	572	574	TTC	177;176;176	T;T;C,G	162;161;160,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5474	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3360	162.6	1	SNP	p	D95G	1	.	.	283	285	GGC	584	586	GGC	174;174;173	G;G;C	157;161;161	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5474	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3360	162.6	1	SNP	p	G95N	0	.	.	283	285	GGC	584	586	GGC	174;174;173	G;G;C	157;161;161	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1584	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1360	116.4	1	SNP	p	G45D	0	.	.	133	135	GGC	513	515	GGC	207;206;209	G;G;C	195;194;196	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	776	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c17.ctg.1	943	81.9	0	.	n	.	0	G98A	SNP	98	98	G	444	444	A	181	A	168	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	776	mtrR_promoter	250	250	99.2	mtrR_promoter.l15.c17.ctg.1	943	81.9	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	184	A	174	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2847	190.9	1	SNP	p	D86N	0	.	.	256	258	GAC	533	535	GAC	192;192;193	G;A;C	181;177;181	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2847	190.9	1	SNP	p	R87I	0	.	.	259	261	CGT	536	538	CGT	192;191;192	C;G;T	183;184;180	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2847	190.9	1	SNP	p	S87R	1	.	.	259	261	CGT	536	538	CGT	192;191;192	C;G;T	183;184;180	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2847	190.9	1	SNP	p	R87W	0	.	.	259	261	CGT	536	538	CGT	192;191;192	C;G;T	183;184;180	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5452	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2847	190.9	1	SNP	p	S88P	0	.	.	262	264	TCC	539	541	TCC	193;194;191	T;C;C	186;185;185	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4302	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2464	173.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1439	1441	GGC	212;208;205	G;G;C	190;187;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1273	1275	GCA	233;232;232	G;C;A	209;208;213	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1276	1278	ATC	233;236;239	A;T;C	215;213;215	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1288	1290	GTG	243;244;241	G;T;G	221;214;214	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1288	1290	GTG	243;244;241	G;T;G	221;214;214	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1792	1794	ACC	192;191;190	A;C;C	173;175;177	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1846	1848	GCG	194;200;198	G;C,G;G	168;155,1;160	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1846	1848	GCG	194;200;198	G;C,G;G	168;155,1;160	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1969	1971	AGC	191;190;187	A;G;C	176;177;172	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1978	1980	GGC	178;177;180	G;G;C	165;162;166	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4096	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2457	166.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1996	1998	CCG	157;158;160	C,G;C;G	107,4;111;110	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5842	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	186.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1604	1606	CCG	188;187;189	C;C;G	163;173;169	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2282	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1729	131.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	538	538	C	157	C	138	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	336	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	39.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	326	328	ACG	90;90;87	A;C;G	81;80;76	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	336	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	39.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	368	370	CAA	42;39;36	C;A;A	37;34;32	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	336	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	405	39.4	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	374	376	TAC	28;26;25	T;A;C	27;26;25	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	447	449	GAA	232;231;232	G,A;A;A	214,1;213;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	K41D	NONSYN	121	123	AAA	456	458	GAC	239;237;235	G,A;A;C,A	220,1;221;219,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	K120N	NONSYN	358	360	AAG	693	695	AAT	202;195;199	A;A;T	183;177;182	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	858	860	TCA	232;232;236	T;C;A	207;206;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	987	989	GTC	210;210;209	G;T,C;C	191;191,1;195	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1059	1061	GTT	224;223;221	G;T;T	205;206;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	0	.	p	.	0	D333V	NONSYN	997	999	GAC	1332	1334	GTC	203;203;204	G;T,A;C	188;180,2;188	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	1	SNP	p	A121D	1	.	.	361	363	GAC	696	698	GAC	196;194;195	G;A;C	179;177;177	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2668	porB1b	1047	1047	98.66	porB1b.l15.c17.ctg.1	1519	175.0	1	SNP	p	D121N	0	.	.	361	363	GAC	696	698	GAC	196;194;195	G;A;C	179;177;177	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	388	porB3	990	116	92.24	porB3.l15.c30.ctg.2	405	32.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	326	328	ACG	72;72;69	A;C;G	66;65;61	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	388	porB3	990	116	92.24	porB3.l15.c30.ctg.2	405	32.4	0	.	p	.	0	T29A	NONSYN	85	87	ACC	359	361	GCC	62;61;58	G;C;C	55;53;51	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	388	porB3	990	116	92.24	porB3.l15.c30.ctg.2	405	32.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	368	370	CAA	37;34;31	C;A;A	32;29;27	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	388	porB3	990	116	92.24	porB3.l15.c30.ctg.2	405	32.4	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	374	376	TAC	23;21;20	T;A;C	22;21;20	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10568	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4780	220.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1042	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	957	108.1	1	SNP	p	V57M	1	.	.	169	171	ATG	522	524	ATG	226;221;223	A;T;G	214;211;210	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
